Key result
Home care for 3 months did not significantly reduce the readmission rate (18.9% vs 25.7%, p=0.488) but significantly decreased mortality (0% vs 11.4%, p=0.034) in patients with Type 2 diabetes discharged after surgery.
Why the study?
More than half of people with diabetes require surgery, but few studies have evaluated how to manage their post-discharge care needs to reduce readmission.
Does home care reduce readmission and mortality in patients with Type 2 diabetes who underwent general surgeries?
RCT (n=72)
Permuted block randomization
Yes
Does home care reduce readmission and mortality in patients with Type 2 diabetes who underwent general surgeries?
Absolute Event Rate: 18.9% vs 25.7%
p-value: p=0.488
A 3-month interprofessional home care program significantly reduced mortality but not readmission rates in patients with Type 2 diabetes following general surgery.
May warrant home care after surgery in type 2 diabetes to reduce mortality; extends RCT evidence on post-discharge interventions.
BACKGROUND: More than one-half of people with diabetes need at least one surgery in their lifespan. Few studies have addressed how to manage the needs of these patients after discharge from the hospital. The present study is designed to determine the effect of home care on readmission of Type 2 diabetic patients who underwent surgical procedures. MATERIALS AND METHODS: The present study was a randomized clinical trial. Sixty-nine patients with Type 2 diabetes undergoing surgery were assigned to the intervention and control groups via blocking order in the selected educational hospitals of Isfahan 2019. Home care was performed for 3 months with interprofessional team approach. Data collection tools were re-admission checklist. Data were entered in SPSS software version 23 and were analyzed by nonparametric tests. RESULTS: The background characteristics in the intervention and control groups were not different. The frequency of readmission in the control and intervention groups from the time of discharge until 3 months later was 25.7% and 18.9%, respectively. Frequency of readmission in the intervention and control groups was not significant in 3 months from discharge, P > 0.05. The mortality rate was 11.4% and 0% in control and intervention groups, respectively, P < 0.05. CONCLUSION: It can be argued that continued home care can decrease the rate of readmission and mortality rate in patients with Type 2 diabetes who will discharge from surgical wards.
No takes yet. Share an insight, caveat, or question.
Faridani et al. (2021) conducted an RCT in Type 2 diabetes undergoing general surgery (n=72). Home care vs. Usual care was evaluated on Readmission rate at 3 months (p=0.488). Home care for 3 months did not significantly reduce the readmission rate (18.9% vs 25.7%, p=0.488) but significantly decreased mortality (0% vs 11.4%, p=0.034) in patients with Type 2 diabetes discharged after surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: